Survival variation of the ER/PR/HER2 subtypes by race in a single institution.

被引：0
|
作者：
Parise, C. [1 ]
Caggiano, V. [1 ]
机构：
[1] Sutter Inst Med Res, Sacramento, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.183
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
183
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Age, race/ethnicity, and the ER/PR/HER2 subtypes in breast cancer.
    Parise, Carol
    Caggiano, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
    Onitilo, Adedayo
    Engel, Jessica
    Greenlee, Robert
    Mukesh, Bickol
    CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) : 4 - 13
  • [3] Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study
    Poorolajal, Jalal
    Nafissi, Nahid
    Akbari, Mohammad Esmaeil
    Mahjub, Hossein
    Esmailnasab, Nader
    Babaee, Ebrahim
    ARCHIVES OF IRANIAN MEDICINE, 2016, 19 (10) : 680 - 686
  • [4] Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers
    Parise, Carol A.
    Caggiano, Vincent
    JOURNAL OF CANCER EPIDEMIOLOGY, 2014, 2014
  • [5] Study in ER/PR and HER2 receptor IHC
    Routhier, Caitlin Ann
    JOURNAL OF HISTOTECHNOLOGY, 2015, 38 (03) : 91 - 95
  • [6] QuantiGene 2.0 Assay for ER, PR and HER2 RNA Levels Is a Useful Adjunctive for the Evaluation of ER, PR and HER2 in Breast Cancer
    Lee, A.
    Chae, B. J.
    Song, B. J.
    Jung, S. S.
    Yim, H. W.
    CANCER RESEARCH, 2009, 69 (24) : 758S - 758S
  • [7] Her2 FISH amplification in ER/PR/Her2 IHC negative breast cancer
    Sahoo, Sunati
    Hwang, Helena
    CANCER RESEARCH, 2015, 75
  • [8] Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes
    Wu Ding
    Dengfeng Ye
    Haifeng Chen
    Yingli Lin
    Zhian Li
    Chuanjian Tu
    Breast Cancer, 2024, 31 : 295 - 304
  • [9] Breast cancer subtypes based on ER/PR and HER2 expression: A population-based experience
    Onitilo, A. A.
    Engel, J.
    Greenlee, R. T.
    Mukesh, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California
    Parise, Carol
    Caggiano, Vincent
    CANCER EPIDEMIOLOGY, 2014, 38 (05) : 556 - 562
12345